Filing Flows › 60 Degrees Pharmaceuticals (SXTP) › Q1 2026 › vs Q4 2025
60 Degrees Pharmaceuticals (SXTP) Q1 2026 vs Q4 2025 (quarter over quarter)
60 Degrees Pharmaceuticals's revenue fell $141K (-47%) from $303K in Q4 2025 to $162K in Q1 2026.
60 Degrees Pharmaceuticals, Q1 2026: revenue $162K (-0.9% year over year), net loss $2.1M, operating cash flow −$2.7M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $162K | $303K | −$141K | -47% |
| Other income, net | $5K | $476K | −$472K | -99% |
| Net loss | $2.1M | $1.4M | $651K | +45% |
| Costs & expenses | $2.3M | $2.2M | $36K | +2% |
| Operating costs | $2.3M | $2.2M | $36K | +2% |
| Cost of revenue | $86K | $121K | −$35K | -29% |
| Operating cash sources | $2.9M | $1.8M | $1.1M | +58% |
| Depreciation & amortization | $26K | $24K | $2K | +10% |
| Share-based compensation | $124K | $112K | $12K | +11% |
| Cash used in operations | $2.7M | $1.7M | $1.0M | +62% |
| Net loss absorbed | $2.1M | $1.4M | $651K | +45% |
| Working capital & other | $801K | $389K | $412K | +106% |
Questions
How much did 60 Degrees Pharmaceuticals's revenue grow quarter over quarter in Q1 2026?
60 Degrees Pharmaceuticals's revenue fell $141K (-47%) from $303K in Q4 2025 to $162K in Q1 2026.